Intellia Therapeutics, Inc. · 8 hours ago
Associate Scientist, Cell Therapy
Cambridge, MA
Full-time
Onsite
Entry, Mid Level
$106K/yr - $130K/yr
2+ years expIntellia Therapeutics, Inc. is dedicated to developing curative genome editing treatments for severe diseases. The Associate Scientist in Cell Therapy will engage in laboratory research focused on CRISPR/Cas9 and mRNA-CAR T cell therapies, conducting experiments and supporting in-vivo studies.
BiotechnologyGeneticsHealth CareMedicalTherapeutics
Responsibilities
Responsible for laboratory activities related to the research and development of CRISPR/Cas9 genome edited and mRNA-CAR T cell therapies for oncology and autoimmune disorders
Execute experiments to assess and optimize delivery of cargo to immune cells and test for functionality in vitro and in vivo
Perform in-vitro assays to quantify cargo delivery to T-cells and perform immunoassays (cytotoxicity and cytokine release) to evaluate potency and specificity of engineered T cells
Support the team by performing in-vivo studies using murine models to evaluate therapeutic efficacy
Work within a matrixed organization to improve understanding of CAR T cell, mRNA, and LNP biology
Qualification
Required
Master's degree in Biological Sciences, Bioengineering, Medical Biotechnology, or a directly related field and at least two years of laboratory experience in industry
Alternatively, candidates with a Bachelor's degree plus at least four years of laboratory experience in industry will be considered
Experience culturing and manipulation of human T cells or PBMCs
Experience with multi-color flow cytometry of T cells with up to 6 markers
Experience with in-vitro T cell assays including cytokine quantification (ELISA or MSD), and cell-based cytotoxicity assays with tumor cell lines
Animal handling experience, including i.v., i.p. and s.c. injections and animal model development
Processing animal tissues and organs (ie. spleen) to single cell suspension for downstream analysis
Benefits
Performance-based annual cash bonus
New hire equity grant
Eligibility to be considered for annual equity awards
Company
Intellia Therapeutics, Inc.
Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.
501-1000 employees
H1B Sponsorship
Intellia Therapeutics, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (13)
2024 (38)
2023 (63)
2022 (46)
2021 (10)
2020 (6)
Funding
Current Stage
Public CompanyTotal Funding
$1.54BKey Investors
OrbiMed
2022-11-30Post Ipo Equity· $300M
2021-06-30Post Ipo Equity· $690M
2020-11-30Post Ipo Equity· $201M
Leadership Team
John Leonard
President and Chief Executive Officer, Member Board of Directors
Edward Dulac
Chief Financial Officer
Recent News
Labiotech UG
2026-01-22
Clinical Trials Arena
2026-01-16
Company data provided by crunchbase